27 filings
8-K
SNPX
Synaptogenix Inc
4 Apr 24
Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing
5:00pm
8-K
SNPX
Synaptogenix Inc
21 Dec 23
Departure of Directors or Certain Officers
5:00pm
8-K
SNPX
Synaptogenix Inc
6 Nov 23
Entry into a Material Definitive Agreement
5:00pm
8-K
SNPX
Synaptogenix Inc
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
SNPX
Synaptogenix Inc
19 Jul 23
Study will evaluate drug’s potential neuro-restorative mechanism(s) of action for improving synaptic health and cognitive function in MS patients
8:55am
8-K
72tf7f9
22 Jun 23
Departure of Directors or Certain Officers
5:14pm
8-K
0pwdv
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
ytxqeykdvdqd
14 Apr 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
rjt2nw5c
7 Mar 23
Results of Operations and Financial Condition
9:05am
8-K
ypc87ajsmw8
17 Feb 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
qwzzrdzh 11gf2wi
28 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
t863 0dtf95q1iqxtx32
16 Dec 22
Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2
9:06am
8-K
q6p2w0
22 Nov 22
Amendments to Articles of Incorporation or Bylaws
8:42am
8-K
cemx3zz
18 Nov 22
Synaptogenix Announces $15 Million Private Placement with Existing Investors
9:05am
8-K
oesdvjj 7emt5
12 Oct 22
Departure of Directors or Certain Officers
6:11pm
8-K
tu17spkpuc5zqk0
16 Aug 22
Changes in Registrant's Certifying Accountant
4:30pm
8-K
mmkbcg
1 Oct 21
Departure of Directors or Certain Officers
5:09pm
8-K
7r09te59x
16 Jul 21
Departure of Directors or Certain Officers
5:15pm
8-K
usg63kjk6
21 Jun 21
Other Events
9:20am
8-K
0yj3 zdapmibo4u2v1u
16 Jun 21
Synaptogenix Announces $12.5 Million Private Placement
5:09pm